tirzepatide salt form TFA (LY3298176 TFA, GIP and GLP-1 receptor agonist)-Therapeutic peptides drug benchmark for in-vivo/in-vitro study Tirzepatide · Target ≥ 99.0%
Pay in 4 interest-free payments of $6.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



























